decemb
tokyo
women
medic
univers
yachiyo
medic
center
nasopharyng
swab
obtain
patient
younger
month
old
hospit
lrtd
previou
report
describ
polymeras
chain
reaction
pcr
nest
pcr
perform
newli
design
primer
posit
sampl
also
determin
use
base
pcr
amplifi
differ
region
viral
genom
q
agil
technolog
tokyo
japan
nucleotid
sequenc
posit
sampl
determin
direct
sequenc
sequenc
kit
bigdy
termin
appli
biosystem
tokyo
japan
use
dna
sequenc
prism
avant
appli
biosystem
pcr
done
respiratori
syncyti
viru
rsv
enteroviru
ev
includ
rhinoviru
coronaviru
hmpv
hbov
adenoviru
adv
parainfluenza
viru
piv
describ
previou
bacteri
cultur
nasopharyng
specimen
done
patient
lrtd
defin
clinic
patient
suspect
lrtd
underw
chest
radiographi
pneumonia
defin
accord
find
ethic
committe
tokyo
women
medic
univers
approv
studi
parent
guardian
patient
gave
inform
consent
patient
mean
age
month
malefemal
wupyv
kipyv
three
wupyv
kipyv
two
wupyv
kipyv
wupyv
kipyv
total
wupyv
five
kipyv
peak
wupyv
detect
found
fig
sampl
posit
sampl
posit
one
respiratori
virus
follow
hbov
n
hmpv
n
rsv
n
ev
n
adv
n
piv
n
sampl
virus
remain
patient
patient
complic
bacteri
infect
determin
cultur
sputum
remain
eight
patient
patient
specimen
posit
wupyv
among
eight
patient
pneumonia
n
bronchiti
n
like
symptom
cough
wheez
high
fever
found
three
patient
data
relat
oxygen
satur
mean
number
white
blood
cell
percentag
neutrophil
protein
mgdl
length
hospit
stay
day
similar
children
lrtd
first
virolog
diagnosi
done
accord
pcr
assay
alon
children
posit
wupyv
half
patient
found
multipl
virus
bacteria
must
also
investig
serolog
analysi
longitudin
pcr
data
show
wupyv
truli
pathogen
children
second
check
microorgan
influenza
viru
mycoplasma
confirm
point
wupyv
patholog
organ
eight
children
wupyv
wupyv
detect
hospit
children
lrtd
japan
two
independ
studi
conduct
japan
separ
tempor
geograph
yield
similar
result
suggest
certain
number
patient
among
japanes
children
addit
clinic
etiolog
studi
wupyv
potenti
pathogen
must
conduct
assess
characterist
epidemiolog
pathogen
